Agency Information Collection Activities; Proposals, Submissions, and Approvals

Federal Register: November 7, 2008 (Volume 73, Number 217)

Notices

Page 66276

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr07no08-87

OFFICE OF NATIONAL DRUG CONTROL POLICY

Paperwork Reduction Act; Notice of Intent To Collect; Comment

Request

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: ONDCP provides opportunity for public comment concerning the collection of information gathered for the purpose of developing and tracking anti-drug advertising for the National Youth Anti-Drug Media

Campaign.

SUMMARY: This action proposes the renewal of three existing data collection instruments used in the production of ONDCP's National Youth

Anti-Drug Media Campaign advertising and Media Campaign tracking.

SUPPLEMENTARY INFORMATION:

1. Purpose

   The National Youth Anti-Drug Media Campaign is in the process of renewing three data collection instruments. These data collection instruments--pre-production qualitative (or ``focus group'') testing of creative advertising concepts (OMB 3201-0011), pre-broadcast quantitative (or ``copy'') testing of developed advertising (OMB 3201- 0006) and a tracking study to measure advertising effectiveness (OMB 3201-0010)--are critical to the continuity and improvement of the Media

   Campaign and are key contributors to the downturn in drug abuse.

   Type of Collections: OMB 3201-0011--Qualitative Research--Focus groups; OMB 3201-0006--Copytesting--15-minute mall intercept interviews; OMB 3201-0010--Tracking Study--15-minute mall intercept interviews.

   Title of Collection: See above.

   Frequency: OMB 3201-0011--Qualitative Research--Quarterly; OMB 3201-0006--Copytesting--Quarterly; OMB 3201-0010--Tracking Study--

   Weekly.

   Affected Public: Teenagers and adult influencers of teenagers.

   Estimated Burden: OMB 3201-0011--Qualitative Research--$11,600; OMB 3201-0006--Copytesting--$16,500; OMB 3201-0010--Tracking Study--

   $21,000.

2. Special Issues for Comment

   ONDCP especially invites comments on: (a) Ways to enhance information quality, utility, and clarity of the collection instruments; and (b) ways to ease the burden on respondents, including the use of automated collection techniques or other forms of information technology.

   Comments: Address comments within 60 days to Mark Krawczyk,

   Executive Office of the President, Office of National Drug Control

   Policy, Washington, DC 20503; by e-mail at MKrawczyk@ondcp.eop.gov; or, by fax at (202) 395-0858. For further information, contact Mr. Krawczyk at (202) 395-6720.

   Signed in Washington, DC, on November 3, 2008.

   Daniel R. Petersen,

   Assistant General Counsel.

   FR Doc. E8-26553 Filed 11-6-08; 8:45 am

   BILLING CODE 3180-02-P